BNET Industries

Market Cap:$1.3B
Last Fiscal Year Sales:$1.0B
  • Public
  • US
Dow Jones Description

The Cooper Companies, Inc. is a rapidly growing specialty medical products company serving the vision care and women's healthcare markets with high-quality products and services through its CooperVision and CooperSurgical business units.

Chief Executive Officer
Robert S. Weiss
Number of Employees 7,400
Contact Information

6140 Stoneridge Mall Rd Ste 590

Pleasanton, California 94588

www.coopercos.c...

(925) 460-3600

NAICS Code Ophthalmic Goods Manufacturing: 339115

Recent Events

  • Esterline, Freddie Surge; Shanda, Moody's Fall

    9/04/09 - Financial Announcement - View Story

  • Opening View: Market Hopeful Job Losses Are Slowing

    6/05/09 - Financial Announcement - View Story

News & Analysis

cooper companies inc. - All News and Analysis

Decision Makers

Name (plus bio) Position
Robert S. Weiss Chief Executive Officer
Jeff McLean President, CooperVision Operations
Benny Kirsh Chief Information Officer
Carol R. Kaufman Cao
Eugene J. Midlock Senior Vice President and Chief Financial Officer
John C. Calcagno Chief Financial Officer and Vice President, Business Development
Albert G. White, III Treasurer & Vice President, IR
B. Norris Battin Vice President, IR & Comm
Daniel G. McBride Vice President and General Counsel
J. Christopher Marmo Vice President, Research & Development
Rodney E. Folden Controller & Vice President
Stanley Zinberg Vice President of Practice Activities, American College of Obstetricians and Gynecologists
Stephen C. Whiteford Vice President
Moses Marx General Partner, United Equities
David Acosta Treasurer & Director, Tax
Kim Duncan Director, IR

Board of Directors

Name (plus bio) Position
A. Thomas Bender Chairman
Donald Press Board of Directors
Jody S. Lindell Board of Directors
Michael H. Kalkstein Board of Directors
Nicholas J Pichotta Board of Directors

Mr. Weiss has served as our President since March 2008 and as our Chief Executive Officer since November 2007. He also served as President of CooperVision, our contact lens subsidiary from March 2007 to February 2008. He previously served as our Chief Operating Officer from January 2005 to October 2007 and as Executive Vice President from October 1995 to October 2007. He served as our Chief Financial Officer from September 1989 to January 2005. He also served as our Treasurer from 1989 to March 2002. Since joining us in 1977, he has held a number of finance positions both with us and Cooper Laboratories, Inc. (our former parent). Mr. Weiss is also a director of Accuray Incorporated, a company that develops and markets a sophisticated robotic radiosurgery system designed to treat tumors, and serves on its Nominating Committee and as Chair of its Audit Committee.

Organization Position Status
The Cooper Companies, Inc. Chief Executive Officer Current
Coopervision Technology, LLC President and CEO Current
Cooper & Company Inc. Executive Vice President and Chief Operating Officer Current
Accuray Incorporated Chairman Current
Accuray Incorporated Board of Directors Current
Coopervision Technology, LLC Board of Directors Current
The Cooper Companies, Inc. Board of Directors Current
Accuray Incorporated Member Current
Coopervision, Inc. President Former
Coopervision Technology, LLC Executive. Vice President & Coo Former
The Cooper Companies, Inc. Coo Former
Coopervision, Inc. Cfo Former
The Cooper Companies, Inc. Executive Vice President Former
Coopervision, Inc. Vice President Former
Coopervision, Inc. Corporate Controller Former
Coopervision, Inc. Treasurer Former
University of Scranton B.S. In Accounting Former

Mr. McLean has served as Executive Vice President, Global Commercial Strategies of CooperVision, our contact lens business, since May 2008. Previously he served as President, the Americas, of CooperVision from June 2005 to April 2008, as President, U.S. Operations of CooperVision from January 2005 through June 2005, and as Vice President, Sales of CooperVision from February 2004 to December 2004. He has also served as Director of Marketing & National Accounts of CooperVision. Before joining CooperVision in September 2002, Mr. McLean was a consultant for Pfizer from February 2002 to August 2002. Prior to that Mr. McLean spent eighteen years at Bausch & Lomb Incorporated holding several management positions, his last as Vice President, Sales & Marketing.

Organization Position Status
The Cooper Companies, Inc. President, CooperVision Operations Current
Coopervision, Inc. President, Americas Former
The Cooper Companies, Inc. Executive Vice President, Commercial Strategies, CooperVision Inc Former
Coopervision, Inc. Vice President, Sales Former
Bausch & Lomb Incorporated Vice President Sales & Marketing Former
Pfizer Inc. consultant Former

Organization Position Status
The Cooper Companies, Inc. Chief Information Officer Current

Ms. Kaufman has served as Senior Vice President of Legal Affairs since December 2004. She has served as Vice President and Chief Administrative Officer since October 1995 and was elected Vice President of Legal Affairs and Secr...

Organization Position Status
Legal Affairs Chief Administrative Officer Current
The Cooper Companies, Inc. Cao Current
Chindex International Inc. Senior Vice President of Legal Affairs, Secretary and Cao Current
The Cooper Companies, Inc. Senior Vice President of Legal Affairs Former
The Cooper Companies, Inc. Vice President Current
The Cooper Companies, Inc. Secretary Current
Coopervision, Inc. Board of Directors Current
Chindex International Inc. Director Current
Legal Affairs Senior Vice President Former
Coopervision, Inc. Vice President, Legal Former
Boston University Undergraduate Degree Former

Mr. Midlock has served as Senior Vice President and Chief Financial Officer since February 2008. Prior to that he served as the Vice President, Finance from November 2007 to February 2008 and as Vice President, Taxes from January 2005 to October 2007. From November 2003 until December 2004 he served as our consultant. During this period he also served as an instructor in the Master of Science in Taxation program of San Jose State University. From 1979 until he retired in 2002 he was a partner and held a number of leadership positions with KPMG.

Organization Position Status
The Cooper Companies, Inc. Senior Vice President and Chief Financial Officer Current
Northern California Partner Former
The Cooper Companies, Inc. Consultant Former
San Jose State University Instructor Former

Chief Financial Officer and Vice President, Business Development of CooperVision, Inc. Mr. Calcagno has served as Chief Financial Officer and Vice President, Business Development for CooperVision since January 2003. From December 1998 through December 2002, he was President, U.S. Operations, of CooperVision. Prior to that he was Vice President of Finance and General Manager of CooperVision's U.S. business. He has also held various other positions within subsidiaries of the Company.

Organization Position Status
The Cooper Companies, Inc. Chief Financial Officer and Vice President, Business Development Current
Coopervision, Inc. CFO Current
Coopervision, Inc. Board of Directors Current
Coopervision, Inc. President, U.S. Operations Former
Coopervision, Inc. Vice President, Business Development Former
Coopervision, Inc. General Manager Former

Mr. White has served as Vice President, Investor Relations since November 2007 and has served as Vice President and Treasurer since joining us in April 2006. Prior to that he served as a Director with KeyBanc Capital Markets for three years and in a number of leadership positions within KeyBank National Association over the prior eight years.

Organization Position Status
The Cooper Companies, Inc. Treasurer & Vice President, IR Current
Coopervision Technology, LLC Current
The Cooper Companies, Inc. Board of Directors Current
Keybanc Capital Markets Director Former
Virginia Polytechnic Institute and State University MBA Former
Virginia Polytechnic Institute and State University BS Former

Mr. Battin has served as Vice President, Investor Relations and Communications since November 1995. Prior to joining the Company, Mr. Battin was Principal Associate of Battin Associates, a healthcare marketing, advertising and public relations consultancy whose client list included the Company. From 1968 to 1991, Mr. Battin held numerous marketing, advertising, public relations and public affairs positions at Allergan, Inc., a multinational manufacturer of eye and skin care products, including Senior Vice President, Public Affairs and Communication.

Organization Position Status
The Cooper Companies, Inc. Vice President, IR & Comm Current
Allergan, Inc. Senior Vice President, Public Affairs and Communication. Former
The Cooper Companies, Inc. Nov, 1995 Former

Organization Position Status
Coopervision, Inc. Vice President Current
Coopervision Technology, LLC Vice President & General Counsel Current
The Cooper Companies, Inc. Vice President and General Counsel Current
Coopervision, Inc. General Counsel Former
Latham & Watkins Attorney Former
The Cooper Companies, Inc. Senior Counsel Former
Stanford Law School Jd Former
Santa Clara University B.S. In Finance Former

Organization Position Status
The Cooper Companies, Inc. Vice President, Research & Development Current
Coopervision, Inc. Vice President, Research & Development Current
Coopervision, Inc. Board of Directors Current
Ocular Sciences, Inc. Vice President of Research & Development Former
Arthur D. Little, Inc. Senior Manager Former

Mr. Folden has served as Corporate Controller since February 2004. He served as Assistant Corporate Controller from March 1994 to February 2004. He has also held a variety of financial positions since joining us in 1987.

Organization Position Status
The Cooper Companies, Inc. Controller & Vice President Current
The Cooper Companies, Inc. Corporate Controller Former

Dr. Zinberg, an obstetrician-gynecologist, has served on the New York State Board for Professional Medical Conduct since November 2008. He also served as Deputy Executive Vice President and Vice President of Practice Activities for the American College of Obstetricians and Gynecologists in Washington, D.C. from 1993 through his retirement in December 2007. From 1981 until 1993 he served as Chief, Obstetrics and Gynecology, and Director, OB-GYN Residency Program at NY Downtown Hospital, where from 1990 through 1992 he also served as President of the Medical Staff and is currently a member of the Board of Trustees. He is certified by the American Board of Obstetrics and Gynecology and is a member of the faculty of the Departments of Obstetrics and Gynecology at New York University School of Medicine, the Cornell University College of Medicine and the Georgetown University School of Medicine. He is the author of numerous editorials, scientific papers and book chapters in the field of women's healthcare. In addition, Dr. Zinberg obtained a Masters Degree in Health Administration, with an emphasis on not-for-profit finance, in 1990 from the Graduate School of Public Administration of New York University. He also serves on the Southampton Town Board of Ethics in Southampton, NY.

Organization Position Status
The Cooper Companies, Inc. Vice President of Practice Activities, American College of Obstetricians and Gynecologists Current
The Cooper Companies, Inc. Board of Directors Current
Medical Staff President Former

Organization Position Status
A.P. Pharma, Inc. Chief Financial Officer and Vice President, Finance Current
The Cooper Companies, Inc. Vice President Current
California State University, Los Angeles B.S. In Business Administration Former

Organization Position Status
Momar, Inc. President Current
The Cooper Companies, Inc. General Partner, United Equities Current
United Equities, Inc. General Partner Current
The Cooper Companies, Inc. Director Current
Berkshire Bancorp Inc. Director Current
The Cooper Companies, Inc. Nominating Committee Chairman Former
Berkshire Bancorp Inc. Chairman of the Board Former

Organization Position Status
The Cooper Companies, Inc. Treasurer & Director, Tax Current

Organization Position Status
The Cooper Companies, Inc. Director, IR Current

Mr. Bender was elected Chairman of the Board in July 2002. He served as President and Chief Executive Officer of the Company from May 1995 through his retirement in October 2007. He also served as President of CooperVision, the Company s contact lens subsidiary, from June 1991 to December 2004. He previously served in various operating roles beginning in October 1992. Between 1966 and June 1991, Mr. Bender held a variety of positions at Allergan, Inc. (a manufacturer of eye and skin care products), including Corporate Senior Vice President, and President and Chief Operating Officer of Herbert Laboratories, Allergan s dermatology division. Mr. Bender also serves on the Board of Directors of iScience Interventional, Inc. and their compensation committee, as well as the Board of Directors for Mission Hospital Foundation in Mission Viejo, CA.

Organization Position Status
Coopervision Technology, LLC President & CEO Current
The Cooper Companies, Inc. Chairman Current
Senorx, Inc. Board of Directors Current
Coopervision Technology, LLC Board of Directors Current
Coopervision, Inc. Chairman & CEO Former
The Cooper Companies, Inc. Chief Executive Officer Former
The Cooper Companies, Inc. President Former
Coopervision, Inc. President Former
Allergan, Inc. president Former
The Cooper Companies, Inc. Coo Former
Allergan, Inc. chief operating officer Former
Allergan, Inc. Corporate Senior Vice President Former
The Cooper Companies, Inc. Senior Vice President Operations Former
Allergan, Inc. Senior Management Positions Former
Senorx, Inc. Committee Chair for Compensation Committee Former
The Cooper Companies, Inc. Board Director Former
University of St. Thomas B.S. In History Former

Executive Vice President, Broadway Management Co., Inc. Mr. Press has been Executive Vice President of Broadway Management Co., Inc., an owner and manager of commercial office buildings, since 1981. Mr. Press is also a principal in Donald Press, P.C., a law firm, located in New York City. Mr. Press is a director of The Berkshire Bank, a wholly owned subsidiary of Berkshire Bancorp Inc. and he serves on its Audit Committee.

Organization Position Status
Berkshire Bank Director Current
Components Specialties, Inc Director Current
The Cooper Companies, Inc. Board of Directors Current
The Cooper Companies, Inc. Corporate Governance Committee Chairman Former
Superior Savings of New England Director Former

Organization Position Status
First Republic Bank Director Current
The Cooper Companies, Inc. Board of Directors Current
PDL BioPharma, Inc. Board of Directors Current
KPMG International partner Former
Stanford University M.B.A. Former
Stanford University B.A Former

Organization Position Status
Opera San Jose, Inc Vice President, Chair of Long Range Planning Current
Coopervision, Inc. Managing Partner, Dechert Llp Current
Coopervision Technology, LLC Jody S. Lindell Executive Officers of the Company Current
The Cooper Companies, Inc. Board of Directors Current
Coopervision Technology, LLC Board of Directors Current
Coopervision, Inc. Board of Directors Current
Opera San Jose, Inc President Former
Dechert Llp Partner Former
Oppenheimer Wolff & Donnelly Llp Partner Former
The Cooper Companies, Inc. Organization & Compensation Committee Chairman Former
Law Foundation Board of Directors Former
Oppenheimer Wolff & Donnelly Llp Board of Directors Former
Opera San Jose, Inc Board Trustee Former

Array

Organization Position Status
The Cooper Companies, Inc. Board of Directors Current
The Cooper Companies, Inc. CEO, CooperSurgical, Inc Former
Coopersurgical, Inc. President Former
Coopervision, Inc. president Former
Coopersurgical, Inc. Co-Founder Former

Executive News

  • Cooper Posts Higher Q3 Profit

    TradingMarkets - 9/03/09 - View Story

  • The Cooper Companies Announces Third Quarter 2009 Results

    Yahoo! Canada - 9/03/09 - View Story

  • The Cooper Companies Announces Third Quarter 2009 Results

    Street Insider - 9/03/09 - View Story

  • CooperVision to Close Norfolk Contact Lens Manufacturing Plant

    Reuters - 8/13/09 - View Story

advertisement
     COO $30.56 +0.24 (0.79% )
Average Volume 586,126
Shares Outstanding 45.18M
Market Cap 1.4B
Year High 31.43
Year Low 10.17
Earnings Per Share 2.19
P/E Ratio 13.95
Dividend 0.06
Yield 0.20
advertisement